TScan Therapeutics
TCRX
TCRX
24 hedge funds and large institutions have $30.4M invested in TScan Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 7 closing their positions.
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
7
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BBA
1
Baker Bros. Advisors
New York
|
$8.76M |
2 |
TCM
2
Tang Capital Management
San Diego,
California
|
$2.35M |
3 |
NM
3
Newtyn Management
New York
|
$782K |
4 |
4
Morgan Stanley
New York
|
$180K |
5 |
5
LPL Financial
San Diego,
California
|
$50K |